Screening for aminoglycoside auditory toxicity in the old. 1990

R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
Section of Medical Statistics, Northwick Park Hospital, Middlesex.

1. We have investigated 22 patients receiving gentamicin, mean (s.d.) age 78 (6) years for auditory toxicity, using a standard audiometric technique in a sound-treated room (Study 1). 2. Use of a portable audiometer might allow a larger and more representative proportion of patients treated with aminoglycosides to be screened for ototoxicity. A method for detecting high frequency loss suitable for use in the ward was evaluated in 12 volunteers aged 27 (4) years (Study 2). 3. The error inherent in taking hearing at the start of treatment as a reference point was measured in 16 patients, aged 81 (8) years, prescribed non-ototoxic antibacterials (Study 3). 4. A significant (P = 0.05) reduction in hearing threshold was detected in Study 1, although psychometric tests revealed unchanged or improved ability to co-operate. This occurred only at 4000 Hz, the highest frequency used. The magnitude of this loss, mean 2.5 dB, was similar to that of the improvement in threshold detected (P = 0.0004) early in the course of treatment in Study 3. Thus, underestimation of ototoxicity is likely. 5. If a change of threshold of 10 dB or more is taken arbitrarily to represent a real change in hearing, then there was a significant excess of patients in Study 1 with losses at 4000 Hz only (P = 0.032). The six with such losses at this frequency were older than the rest. However, there was a significant (P less than 0.02) positive correlation between log mean predose serum gentamicin concentration and age. Thus, it remains to be determined whether presbyacusis sensitizes those hair cells which it does not destroy to toxic damage. 6. The cumulative dose of gentamicin (for a course of the duration given) was calculated according to published prescribing aids. There was no systematic reduction in the ratio of the dose recommended by a given aid to the dose prescribed in the six with hearing losses as defined above. 7. In Study 2, thresholds obtained at 6000 Hz in the open ward were, on average, 0.9 dB higher than in the sound treated room, but the effect of venue did not reach statistical significance. In the morning thresholds were marginally, but significantly (P = 0.04), lower than in the afternoon. Precision, as measured by the standard deviation of replicate determination, was independent of test conditions. Using multiple (ten) threshold determinations appeared to improve resolution.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006316 Hearing Loss, High-Frequency Hearing loss in frequencies above 1000 hertz. Hearing Loss, High Frequency,High-Frequency Hearing Loss
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001299 Audiometry The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds. Audiometries
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
June 1979, Antimicrobial agents and chemotherapy,
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
August 1979, American journal of hospital pharmacy,
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
April 1996, Nature medicine,
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
January 1994, Archives of ophthalmology (Chicago, Ill. : 1960),
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
January 1983, Antimicrobial agents and chemotherapy,
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
April 1992, Archives of ophthalmology (Chicago, Ill. : 1960),
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
September 1986, Lancet (London, England),
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
September 1982, Lancet (London, England),
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
December 1993, The Journal of infectious diseases,
R Cheung, and P Clark, and P W Nicholson, and A A Deshmukh, and C J O'Neill, and S M Dobbs, and R J Dobbs
June 1985, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!